Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): National Spina Bifida Patient Registry-Clinic Demonstration Project (U01), Funding Opportunity Announcement (FOA) DD11-001, Initial Review, 9578 [2011-3708]

Download as PDF 9578 Federal Register / Vol. 76, No. 34 / Friday, February 18, 2011 / Notices Dated: February 14, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Conducting Public Health Research Through the Field Epidemiology and Laboratory Training Programs (FETPs/FELTPs), Funding Opportunity Announcement (FOA) GH11–001, Initial Review Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): National Spina Bifida Patient Registry—Clinic Demonstration Project (U01), Funding Opportunity Announcement (FOA) DD11–001, Initial Review [FR Doc. 2011–3710 Filed 2–17–11; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention WReier-Aviles on DSKGBLS3C1PROD with NOTICES National Center for Environmental Health/Agency for Toxic Substances and Disease Registry (NCEH/ATSDR); Notice of National Conversation on Public Health and Chemical Exposures Leadership Council Meeting Time and Date: 8:30 a.m.–5 p.m., Friday, March 11, 2011. Location: Washington Plaza Hotel, 10 Thomas Circle, NW., Washington, DC 20005. Status: Open to the public, on a first come, first served basis, limited by the space available. An opportunity for the public to listen to the meeting by phone may be provided; see ‘‘contact for additional information’’ below. Purpose: This is the final scheduled meeting of the National Conversation on Public Health and Chemical Exposures Leadership Council. The National Conversation on Public Health and Chemical Exposures is a collaborative initiative through which many organizations and individuals are helping develop an action agenda for strengthening the nation’s approach to protecting the public’s health from harmful chemical exposures. The Leadership Council provides overall guidance to the National Conversation project and will be responsible for issuing the final action agenda. For additional information on the National Conversation on Public Health and Chemical Exposures, visit this Web site: https://www.atsdr.cdc.gov/ nationalconversation/. Meeting agenda: The Leadership Council will finalize the Action Agenda. Contact for additional information: If you would like to receive additional information on attending the meeting or the potential opportunity to listen to the meeting by phone, please contact: nationalconversation@cdc.gov or Julie Fishman at 770–488–0629. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 12:30 p.m.–3 p.m., April 13, 2011 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Conducting Public Health Research Through the Field Epidemiology and Laboratory Training Programs (FETPs/ FELTPs), FOA GH11–001, initial review.’’ Contact Person for More Information: Diana Bartlett, M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road, N.E., MS– D72 (attn: Christine Morrison), Atlanta, Georgia 30333, Telephone: (404) 639–4938, E-mail dbartlett@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: February 14, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2011–3709 Filed 2–17–11; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Clinical Laboratory Improvement Advisory Committee Correction: This notice was published in the Federal Register on January 31, 2011, Volume 76, Number 20, page 5379. The location of the meeting has changed as follows: BILLING CODE 4163–18–P Jkt 223001 [FR Doc. 2011–3708 Filed 2–17–11; 8:45 am] Centers for Disease Control and Prevention [FR Doc. 2011–3654 Filed 2–17–11; 8:45 am] 13:57 Feb 17, 2011 Time and Date: 1 p.m.–4 p.m., March 31, 2011 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the initial review, discussion, and evaluation of the ‘‘National Spina Bifida Patient Registry—Clinic Demonstration Project (U01), FOA DD11–001, initial review.’’ Contact Person for More Information: Hylan D. Shoob, PhD, M.S.P.H., Scientific Review Officer, Office of the Associate Director for Science, Office of the Director, CDC, 1600 Clifton Road, NE., Mailstop D–72, Atlanta, GA 30333, Telephone: (404) 639– 4796, E-mail: hshoob@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: February 14, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. BILLING CODE 4163–18–P Dated: February 9, 2011. Tanja Popovic, Deputy Associate Director for Science, Centers for Disease Control and Prevention. VerDate Mar<15>2010 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 E:\FR\FM\18FEN1.SGM 18FEN1

Agencies

[Federal Register Volume 76, Number 34 (Friday, February 18, 2011)]
[Notices]
[Page 9578]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-3708]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): National Spina Bifida Patient Registry--Clinic 
Demonstration Project (U01), Funding Opportunity Announcement (FOA) 
DD11-001, Initial Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Time and Date: 1 p.m.-4 p.m., March 31, 2011 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the initial 
review, discussion, and evaluation of the ``National Spina Bifida 
Patient Registry--Clinic Demonstration Project (U01), FOA DD11-001, 
initial review.''
    Contact Person for More Information: Hylan D. Shoob, PhD, 
M.S.P.H., Scientific Review Officer, Office of the Associate 
Director for Science, Office of the Director, CDC, 1600 Clifton 
Road, NE., Mailstop D-72, Atlanta, GA 30333, Telephone: (404) 639-
4796, E-mail: hshoob@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: February 14, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.

[FR Doc. 2011-3708 Filed 2-17-11; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.